Why Patients Switch: Dose Equivalents & Cost Comparison
Understanding Mounjaro Wegovy Dose Equivalent Transitions
When considering switching from Mounjaro (tirzepatide) to Wegovy (semaglutide), understanding dose equivalents is essential for maintaining treatment effectiveness. Mounjaro is a dual GIP and GLP-1 receptor agonist, whilst Wegovy targets GLP-1 receptors specifically. Although direct dose equivalents don't exist due to different mechanisms, prescribers typically recommend starting Wegovy at 0.25mg weekly regardless of your previous Mounjaro dose. This approach ensures safe dose escalation following the licensed protocol.
The transition requires careful prescriber supervision, as stopping one GLP-1 medication and starting another involves different pharmacokinetic profiles. Mounjaro doses range from 2.5mg to 15mg weekly, whilst Wegovy escalates from 0.25mg to 2.4mg maintenance dose. Your prescriber will determine the appropriate Wegovy starting dose based on your clinical response to Mounjaro, current tolerance, and individual circumstances. Both medications are available through EverydayMeds, ensuring continuity of care during your transition.
Mounjaro Wegovy Dose Equivalent Cost Analysis & Savings
Switching from private Mounjaro prescriptions to Wegovy can deliver significant monthly savings. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose with code FIRST40, whilst maintenance 2.4mg costs £209.99. Our bundle options provide additional value – the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first three months of dose escalation. Returning customers benefit from code DOSE25 applied at checkout, maintaining competitive pricing throughout treatment.
Private Mounjaro typically costs £150-250+ monthly, making Wegovy a cost-effective alternative for many patients. The Ultimate Stability Trio provides three months of maintenance 2.4mg Wegovy for £649.99 – representing substantial savings compared to equivalent Mounjaro duration. Our GPhC-registered pharmacy (#9012878) ensures you receive authentic prescription-only medicine with full clinical oversight, combining cost savings with clinical safety during your dose equivalent transition.
Clinical Evidence Supporting Mounjaro Wegovy Dose Equivalent Switches
Both Mounjaro and Wegovy demonstrate robust clinical efficacy in weight management trials, though direct comparison requires careful interpretation due to different study designs. Wegovy's STEP trials showed patients achieving approximately 15% average weight loss at 68 weeks when used alongside diet and exercise, as reported by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management.
Mounjaro's SURMOUNT trials indicated similar efficacy ranges, though these involved different populations and methodologies. When switching between treatments, your prescriber considers your individual response pattern, tolerance profile, and clinical goals rather than comparing trial outcomes directly. Both medications require prescription-only medicine oversight and work most effectively alongside a reduced-calorie diet and increased physical activity.
How Wegovy Works: Mechanism for Mounjaro Wegovy Dose Equivalent Transitions
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, helping regulate appetite and food intake. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy specifically targets GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. This mechanism may help reduce food cravings and support portion control throughout your treatment journey. The once-weekly FlexTouch pen delivers consistent medication levels, maintaining appetite suppression between doses. When transitioning from Mounjaro, this focused GLP-1 action provides reliable weight management support with a well-established clinical profile spanning several years of real-world use.
Ordering Process for Your Mounjaro Wegovy Dose Equivalent Switch
Starting your switch from Mounjaro to Wegovy through EverydayMeds takes just three minutes with our online clinical assessment, covering your medical history, current Mounjaro dose, and reasons for switching. Our prescribers review applications within three working days (24-hour express option available), ensuring thorough evaluation of your dose equivalent requirements and transition safety. Once approved, we dispatch your Wegovy via next-day cold-chain delivery, maintaining the 2-8°C temperature throughout transport. Our GPhC-registered pharmacy (#9012878) coordinates with your current prescriber when necessary, ensuring seamless treatment continuity. The entire process from assessment to delivery typically completes within one week, minimising any treatment gap during your medication transition.
Storage Advantages: Wegovy vs Mounjaro Dose Equivalent Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to six weeks once removed from the fridge, whilst Mounjaro requires refrigeration or allows only 21 days at room temperature. This storage advantage proves particularly valuable for travel, work situations, or lifestyle flexibility when managing your dose equivalent transition. The FlexTouch pen system provides precise dose delivery with clear dose escalation from 0.25mg through 2.4mg maintenance, each pre-filled pen containing four weekly doses. Store unused pens in your fridge at 2-8°C, and once in use, either refrigerate or keep at room temperature as convenient. This practical advantage, combined with established dose escalation protocols, makes Wegovy an attractive option for patients seeking reliable, flexible weight management treatment alongside their reduced-calorie diet and exercise programme.
Mounjaro Wegovy Dose Equivalent Switch: Timeline & Expectations
Planning your Mounjaro to Wegovy dose equivalent switch requires understanding realistic timelines and clinical expectations during transition. Most prescribers recommend allowing 1-2 weeks between stopping Mounjaro and starting Wegovy to assess baseline appetite and avoid potential interaction effects, though individual protocols may vary. Your new Wegovy journey begins with the standard 0.25mg dose regardless of your previous Mounjaro strength, ensuring safe tolerance building with the different receptor activity profile.
Appetite suppression typically returns within 2-3 weeks of starting Wegovy, with full therapeutic effect developing over 8-12 weeks as you progress through dose escalation. Some patients experience temporary appetite increase during the medication gap, which normalises once Wegovy reaches therapeutic levels. Your prescriber monitors this transition closely, adjusting timelines based on your individual response and ensuring optimal outcomes throughout the dose equivalent switch process.
Complete Your Mounjaro Wegovy Dose Equivalent Switch Today
Ready to make the switch from Mounjaro to Wegovy with expert dose equivalent guidance? EverydayMeds streamlines your transition with comprehensive clinical assessment, competitive pricing from £79.99, and next-day delivery once approved. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for continued savings throughout treatment. Our experienced prescribers understand the nuances of GLP-1 medication switches, ensuring your transition maintains clinical effectiveness whilst potentially reducing monthly costs. Start your three-minute assessment today at everydaymeds.co.uk/collections/weight-loss and join thousands of patients who've successfully switched treatments with our support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
